|
Market Closed -
Australian S.E.
09:19:59 23/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.009500 AUD | +5.56% |
|
-5.00% | -36.67% |
| 08-26 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-25 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 5.6M 3.94M 3.46M 3.25M 2.98M 5.56M 378M 39.07M 15.15M 193M 14.81M 14.48M 624M | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.41M 4.52M 3.97M 3.72M 3.41M 6.37M 432M 44.75M 17.35M 221M 16.96M 16.58M 715M | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
95.37% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUXF | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript: Acrux Limited
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 16/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| 1 day | +5.56% | ||
| 1 week | -5.00% | ||
| Current month | -9.52% | ||
| 1 month | -5.00% | ||
| 3 months | -32.14% | ||
| 6 months | -13.64% | ||
| Current year | -36.67% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.56% | -5.00% | -36.67% | -76.25% | 3.77M | ||
| +1.01% | +1.63% | +13.44% | +64.70% | 46.34B | ||
| -1.02% | -2.67% | +38.33% | +108.43% | 37.12B | ||
| +0.67% | +6.47% | +12.98% | +96.46% | 12.13B | ||
| -0.08% | +2.37% | -10.32% | +16.62% | 11.7B | ||
| +0.19% | 0.00% | +19.82% | +140.74% | 8.99B | ||
| +0.56% | +0.08% | +26.32% | +37.72% | 7.25B | ||
| +0.55% | +4.36% | +22.66% | +208.30% | 7.27B | ||
| -0.06% | +1.51% | +38.94% | -16.76% | 7.13B | ||
| -0.64% | +4.66% | -40.29% | +10.76% | 5.16B | ||
| Average | +0.67% | +1.49% | +8.52% | +59.07% | 14.31B | |
| Weighted average by Cap. | +0.16% | +0.75% | +18.77% | +79.50% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.49M 3.16M 2.77M 2.61M 2.38M 4.45M 302M 31.3M 12.14M 155M 11.86M 11.6M 500M | 6.58M 4.63M 4.07M 3.82M 3.5M 6.53M 443M 45.9M 17.8M 227M 17.4M 17.01M 733M |
| Net income | -5.94M -4.18M -3.68M -3.45M -3.16M -5.9M -401M -41.47M -16.08M -205M -15.71M -15.37M -662M | -604K -425K -373K -351K -321K -599K -40.7M -4.21M -1.63M -20.82M -1.6M -1.56M -67.3M |
| Net Debt | 2.77M 1.95M 1.71M 1.61M 1.47M 2.75M 187M 19.34M 7.5M 95.55M 7.33M 7.17M 309M | 813K 572K 503K 472K 432K 807K 54.79M 5.67M 2.2M 28.02M 2.15M 2.1M 90.58M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | A$0.009500 | +5.56% | 65,000 |
| 21/09/26 | A$0.009000 | -10.00% | 463,702 |
| 18/09/26 | A$0.0100 | 0.00% | 1,073,371 |
| 17/09/26 | A$0.0100 | 0.00% | 492,116 |
| 16/09/26 | A$0.0100 | 0.00% | 1,000,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















